The ability to monitor and manipulate epiblast cells in and around the primitive streak of the mouse embryo is important for investigating how cells maintain potency and how distinct cell fates are established. Here, we report development of a key resource for such studies, a mouse line in which a tamoxifen-inducible Cre recombinase construct replaces an endogenous gene, 
Introduction
Epiblast cells in early mouse embryos contribute to all three germ layers, endoderm, mesoderm, ectoderm/neuro-ectoderm and this is gradually restricted as development proceeds.
Once the primitive streak has formed, adjacent epiblast cells, known as the caudal lateral epiblast (CLE), appear to contribute largely to neural and mesodermal lineages. Evidence for this comes from retrospective clonal analysis, which predicts that some CLE cells become neuro-mesodermal progenitors (NMps) that then persist during body axis elongation (Henrique et al., 2015; Tzouanacou et al., 2009 ) and also from homotopic grafting of groups of epiblast cells Wymeersch et al., 2016) . Some NMps are also located more medially in the node streak border (NSB), which additionally includes presumptive notochord cells Wilson, 2002, 2007; Tsakiridis et al., 2014; Wymeersch et al., 2016) . Unique markers for NMps have yet to be identified, but co-expression of early neural and mesodermal markers, Sox2 and Brachyury (Bra) correlates well with the predicted location of these cells in the embryo (Henrique et al., 2015; Tsakiridis et al., 2014; Wymeersch et al., 2016) .
Furthermore, embryonic stem (ES) cell derived cells co-expressing these genes readily differentiate into neural or mesodermal lineages in vitro (Gouti et al., 2014; Turner et al., 2014) and this appears to be the case at the single cell level (Tsakiridis and Wilson, 2015) . Neural tissue generated by epiblast close to the primitive streak contributes to posterior hindbrain and spinal cord (Forlani et al., 2003; Lawson et al., 1991; Lawson and Pedersen, 1992) . However, about mid-way through body axis elongation amniote embryos form a tailbud and subsequent neural tissue is now produced by secondary neurulation of a core of condensed mesenchyme (Schoenwolf, 1984) . Tailbud formation involves internalisation of remnants of the primitive streak, however, the precise fate of the CLE and the role(s) of its derivatives in the continued generation of neural and mesodermal tissue is poorly understood.
The ability to manipulate gene expression in the CLE will allow detailed fate mapping of this cell population as well as facilitate investigation of the bipotent cell state and the mechanisms that establish neural and mesodermal differentiation programmes in vivo. The latter involves the coordinated onset of tissue specific differentiation genes and a change in cell behaviour as cells undergo epithelial to mesenchymal transition to become mesoderm. Here we report development of a key resource for such studies, a mouse line in which a tamoxifeninducible Cre recombinase construct replaces an endogenous gene whose expression demarcates the CLE.
The NK-1 homeobox 2 transcription factor, Nkx1.2, also known as Sax1, is the earliest known CLE expressed gene and it distinguishes this epiblast cell population from differentiating neural and mesoderm tissue (Spann et al., 1994) . Nkx1.2 is a homologue of the Drosophila NK-1/S59 gene, which is expressed in ganglion mother cells, transit-amplifying cells of the fly central nervous system that generate neurons or glia, and also in muscle founder cells and their progenitors as well as midgut cells (Bate, 1990; Dohrmann et al., 1990) . Nkx1.2 is widely conserved across species; representatives are present in chordates and helminthes as well as many vertebrates. In the mouse, a paralogous gene Nkx1.1 (Sax2) has been identified (Bober et al., 1994; Simon and Lufkin, 2003) and two closely related Nkx1 genes have been described in the Zebrafish (Bae et al., 2004) .
The expression pattern of Nkx1.2 has been characterised in chick, mouse and Zebrafish (Bae et al., 2004; Rangini et al., 1989; Schubert et al., 1995; Spann et al., 1994) . In the chick, Nkx1.2 (originally named cHox3 and later cSax1) is detectable at early primitive streak stages ( (Hamburger and Hamilton, 1951) HH 2), but is only visualised by mRNA in situ hybridisation after formation of the first few somites, when it appears in the CLE/stem zone (Delfino-Machin et al., 2005; Rangini et al., 1989; Spann et al., 1994) . This earliest expression then persists in the CLE and expands slightly rostral into the preneural tube (adjacent to presomitic mesoderm) during body axis elongation (Delfino-Machin et al., 2005) . Later phases of expression are not characterised in detail in the chick, but include a subset of interneurons in the spinal cord/hindbrain and expression in the ventral midbrain by HH15 (Schubert and Lumsden, 2005) .
In the mouse, Nkx1.2 is first detected at E7 in the forming CLE next to the primitive streak, is retained until almost the end of axial elongation (E12.5) and is consistently downregulated in neural tissue adjacent to the most recently formed somite (Schubert et al., 1995) . A later phase of Nkx1.2 expression is detected from stages (E10-10.5) in bilateral ventral stripes of interneurons in more rostral spinal cord as well as in rhombomere 1. At this time, Nkx1.2-expressing cells also appear in discrete cell populations in the developing brain, including the ventral midbrain (Schubert et al., 1995) where, in the chick, Nkx1.2 specifies the cells contributing to the medial longitudinal fascicle (Schubert and Lumsden, 2005) .
Regulation of Nkx1.2 in the CLE has been studied in chick and mouse embryos. In the chick, removal of notochord, somites or presomitic mesoderm does not alter Nkx1.2 expression assessed at a late time point when new presomitic mesoderm, but not notochord or somites has been regenerated (Spann et al., 1994) . Subsequent work showed that signals from the presomitic mesoderm promote Nkx1.2 onset as the CLE/stem zone forms and that the FGFR/Erk pathway is required for maintenance of Nkx1.2 in CLE cells; however, FGF alone is insufficient to induce Nkx1.2 in this cell population (Delfino-Machin et al., 2005; Diez del Corral et al., 2002) . Consistent with these data, Nkx1.2 expression is lost in mice mutant for the early mesodermal gene Bra, which lacks caudal presomitic mesoderm (Schubert et al., 1995) . The discrete downregulation of Nkx1.2 as neural differentiation commences is regulated by signals from the more rostral differentiating presomitic mesoderm (Diez del Corral et al., 2002) . This likely reflects the action of retinoic acid, which is synthesized in this tissue and inhibits Fgf8 expression in the stem zone/CLE (Diez del Corral et al., 2003; Kumar and Duester, 2014; Sirbu and Duester, 2006) . Intriguingly, recent work shows that Nkx1.2 in turn promotes Fgf8 transcription (Sasai et al., 2014) , further linking this transcription factor to signalling pathways that regulate differentiation along the body axis. Consistent with this, inhibition of Nkx1.2 leads to precocious expression of neural differentiation genes including Pax6 (Sasai et al., 2014) .
However, Pax6 mutants exhibit normal Nkx1.2 expression indicating that reciprocal repression by Pax6 is not required to restrict Nkx1.2 to the CLE (Schubert et al., 1995) . As noted above, many cells in the CLE/Nkx1.2 domain co-express Sox2 and Bra (Delfino-Machin et al., 2005; Olivera-Martinez et al., 2012; Tsakiridis and Wilson, 2015) and this bipotent cell state can be induced in differentiating mouse and human ES cells by a combination of FGF and Wnt signalling (Gouti et al., 2014; Tsakiridis et al., 2014 ) (reviewed in (Henrique et al., 2015) ). Such CLE-like cells also express Nkx1.2 (Gouti et al., 2014; Tsakiridis et al., 2014) and so it is likely that in the embryo Wnt signalling together with FGF promotes Nkx1.2. This transcription factor has further been shown to induce Bra expression in P19 cells in part by repressing expression of Tcf3 (Tamashiro et al., 2012) ; a step that augments Wnt induction of Bra (Marikawa et al., 2009; Tanaka et al., 2011) and so further links Nkx1.2 to maintenance of this bipotent state.
Here, we present a detailed description of endogenous Nkx1.2 expression in the mouse embryo and the creation and characterisation of a mouse line in which tamoxifen-inducible Cre recombinase is cloned in place of the endogenous Nkx1.2 gene. We demonstrate that this line can be used to manipulate gene expression in the CLE/tailbud and provide a detailed fate map of these cell populations. This includes a novel Nkx1.2 domain in the tailbud mesenchyme, which contains cells co-expressing neural and mesodermal genes and that contributes to both neural and mesodermal lineages.
Results and Discussion
Nkx1.2 is expressed in the caudal epiblast from E7 and within the tailbud from E10.5 to
E11.5
To document in detail Nkx1.2 expression in developing mouse embryos, we carried out RNA in situ hybridisation in whole embryos throughout the period of body axis elongation. We then localised transcripts to specific cell populations in transverse sections. In agreement with a previous report (Schubert et al., 1995) , Nkx1.2 transcripts were first detected at E7-7.5 in the epiblast in the region of and adjacent to the node and the primitive streak, known as the CLE; (Schoenwolf, 1984) . At E11.5 Nkx1.2 transcripts continue to be detected in the caudal-most neural tissue and contiguous mesenchyme of the tailbud ( Figure 1J , K). By E12.5, when elongation of the tail is coming to a halt, Nkx1.2 expression is lost ( Figure 1L , M). Nkx1.2 is also detected outside the caudal region in a sub-population of motor neurons in the hindbrain and spinal cord at E10.5 ( Figure 1N ) and in the medial longitudinal fascicle of the midbrain (Schubert et al., 1995) (Figure 1O , Oa). Taken together, these data show that Nkx1.2 is a consistent marker of the CLE and newly generated caudal neural progenitors throughout body axis elongation. An intriguing possibility is that the novel Nkx1.2 domain found in tailbud mesenchyme may additionally identify the cellular source of the secondary neural tube. Caudal to the CNH, and similar to E10.5, Nkx1.2 was transcribed in the forming neural tube but also in a broad tailbud mesenchyme domain. The CreER T2 sequence was knocked in to this locus using standard targeting methods in C57BL/6 ES cells by Taconic Biosciences. The DNA constructs used are summarised in Figure   2 . Two breeding pairs of C57BL/6-Nkx1.2 tm2296(Cre-ER(T2))Arte (Nkx1.2CreER T2 ) heterozygous mice were provided by Taconic. These mice carried a puromycin-expressing cassette flanked by FLP sites, which was removed upon crossing to Flp-expressing mice. The resulting animals were then bred to the homozygous condition to establish a breeding colony.
Figure 2 Strategy to knock-in the CreER T2 cassette into the Nkx1.2 genomic locus. Targeting vector designed to insert into the downstream region of exon 1 of the mouse Nkx1.2 locus by homologous recombination. Positive clones were injected into mouse blastocysts and transferred to mice. The resulting chimeric mice were bred to Flp Deleter mice that ubiquitously express Flp recombinase to remove the puromycin selection marker to give rise to the Nkx1.2CreER T2 mouse line. SHA, short homologous arm; LHA, long homologous arm; KI, knock-in.
Next, to label Nkx1.2-expressing cells in the developing embryo, homozygous Nkx1.2CreER T2 females were mated with heterozygous or homozygous males harbouring a loxP-flanked STOP sequence upstream of a YFP reporter gene under the control of the ubiquitous ROSA26 promoter (ROSA26-floxed-stop-YFP knock-in mice) (Srinivas et al., 2001 Figure 3A , B) and so was consistent with the pattern of endogenous Nkx1.2 transcripts at ~E7.5 (Schubert et al., 1995) ( Figure 1B , C). To assess potential spontaneous CreER T2 recombination in Nkx1.2CreER T2 mice, we next looked at YFP expression in the absence of tamoxifen induction in E8.5 embryos.
All these embryos showed low levels of spontaneous recombination, from 4 to 9 YFP + cells per embryo (6 ± 1 cells/embryo, mean and s.e.m.) ( Figure 3C ). The close proximity and number of YFP + cells suggests that they originate from one recombination event; given that it takes ~ 4h to detect YFP, that cells have a cell cycle of ~6-7h (Snow, 1977; Tzouanacou et al., 2009) A day later, in E9.5 embryos, again a few scattered cells were located in the midbrain and also the roof of the anterior hindbrain and as well as the developing eye ( Figure 4C ). The rostral-most limit of contiguous YFP labelling was now clearly located in the hindbrain just rostral to the otic vesicle in rhombomere 5 ( Figure 4C Taken together, these findings suggest that the majority of descendants of E7.5 Nkx1.2-expressing cells generate neural tube and trunk mesoderm (except axial mesoderm), and that some cells labelled at this early stage contribute to surface ectoderm and to the hindgut endoderm ( Table 1 ). The latter is consistent with direct fate mapping of single cells (Lawson et al., 1991; Lawson and Pedersen, 1992) and of cell groups (Tam and Beddington, 1987; Wilson and Beddington, 1996) in the early primitive streak which all indicate that the gut endoderm lineage is derived from primitive streak epiblast prior to E8.5. Between E9.5-10.5, axial progenitors complete trunk formation and begin tail formation.
As contribution patterns at E9.5 are largely elaborated in the body axis at E10.5, we focused here on the E10.5 tailbud region. Here most of the caudal body derives from cells that expressed Nkx1.2 at E7.5, including cells in the neural tube and paraxial mesoderm, with occasional cells in the hindgut and surface ectoderm, and very rarely in axial mesoderm (notochord) ( Figure 4D , Da-c) ( Table 1) . Formation of the tailbud involves the ventral bending of the tail fold, which brings the posterior primitive streak to the ventral side, and the two lateral edges of the posteriormost primitive streak form the ventral ectodermal ridge (VER) (Goldman et al., 2000; Gruneberg, 1956) . Consistent with the origin of this structure in primitive streak epiblast, YFP + cells labelled at E7.5 were present in the VER at E10.5 (Figure 4Dc ). These findings indicate that cells that expressed Nkx1.2 at E7.5 or their descendants persist in the caudal end of the embryo at E10.5 and continue to generate largely neural tissue and paraxial mesoderm.
Nkx1.2CreER T2 labels Sox2/Bra co-expressing cells
In the developing embryo, there is evidence for a neuromesodermal progenitor (NMp) cell population in the CLE and the NSB, where Nkx1.2 is expressed, that contributes to neural and paraxial mesoderm lineages. This is based on retrospective clonal lineage analysis (Tzouanacou et al., 2009 ), grafting of cell groups in mouse Wilson, 2002, 2007; Wymeersch et al., 2016) , and labelling of small cell groups in chick embryos (Brown and Storey, 2000) . NMps made in vitro also express Nkx1.2. (Gouti et al., 2014) . A key hallmark of NMps is the co-expression of the early neural and mesodermal markers Sox2 and Bra (Garriock et al., 2015; Tsakiridis et al., 2014; Wymeersch et al., 2016) . To establish whether Nkx1.2CreER T2 /YFP-labelled cells include NMps, we sought to identify YFP-labelled cells that co-express Sox2 and Bra by immunocytochemistry. Nkx1.2CreER T2 /YFP embryos exposed to tamoxifen at E7.5 and assessed at E8.5 (n=7 embryos) show that most CLE YFP + cells in which Nkx1.2 expression is driven express Sox2, and that a subset of such cells located in the CLE/NSB co-express Bra ( Figure 5A ). In embryos examined a day later, at E9.5 (n=4 embryos), YFP + cells in the CLE/NSB continue to co-express Sox2 and Bra ( Figure 5B ). YFP + cells, however, are absent from the caudal end of the notochord, where cells express high levels of Bra protein (Wymeersch et al., 2016) (Figure 5B) . Similarly, at E10.5 (n=7 embryos), YFP + cells labelled at E7.5 and/or their progeny co-express Sox2 and Bra in the neuroectoderm of the CNH region ( Figure 5C ), where grafting experiments indicate that NMps reside at this stage (Cambray and Wilson, 2002) . Given this co-expression of neural and mesodermal genes, we propose here to name this medial mesenchymal cell population the neuromesodermal lip (NML) (Figure 5Cd , Dd).
Importantly, this medial cell group coincides with the novel Nkx1.2 domain identified above (Figure 1Ib-c) , raising the possibility that these mesenchyme cells, which exhibit neural gene expression, are not only the source of neural tissue generated by secondary neurulation, but may also give rise to new paraxial mesoderm in the tailbud.
Nkx1.2CreER T2 cells continue to make neural and mesodermal tissue in the developing tailbud
To test whether late E10.5 Nkx1.2-expressing cells indeed retain NM potential, timedpregnant Nkx1.2CreER T2 /YFP mice were exposed to tamoxifen at E10.5 and embryos assessed a day later, at E11.5. In these embryos, labelled cells contributed to neural and mesodermal tissues, but were now not found in the hindgut or surface ectoderm, (n=13 embryos, 9 assessed in sections) ( Figure 6 ). Labelled cells in the spinal cord were found from immediately below the hindlimb (opposite somite ~36) to the tailbud, while labelled cells in the paraxial mesoderm were found only in the newly emerged presomitic mesoderm (compare Overall, these data document the restriction of caudal lateral epiblast cell fates, but support the possibility that bipotent neuromesodermal progenitors persist to the end of axis elongation and contribute to neural tissue formed by secondary neurulation.
Materials and methods

Mice and tamoxifen administration
To make a tamoxifen stock solution, tamoxifen powder (Sigma T5648) was dissolved in vegetable oil to a final concentration of 40 mg/ml and sonicated to bring to solution. The tamoxifen stock solution was stored at -20 ºC for up to 3 months. The morning of the plug was considered (E0.5). At various stages of pregnancy, Nkx1.2CreER T2 /YFP females were given a single 200µl dose of tamoxifen (of the 40 mg/ml stock) via oral gavage. Mice were monitored for 6 hours and when required sacrificed following schedule 1 of the Animals (Scientific Procedures) Act of 1986. Embryos were dissected in cold PBS and fixed in cold 4% PFA for 2 hours. Gastrula embryos were staged according to (Downs and Davies, 1993) and at later stages by standard morphological criteria.
Genotyping
Genotyping by standard methods was performed to maintain the homozygous line using the following PCR conditions: 95°C, 5 min and then 95°C, 30s; 60°C, 30 s; 72°C, 1 min for 35 cycles followed by 72°C, 10 min.
A DNA quality control and a test reaction were carried out in parallel for the KI allele, the wild-type (WT) allele, and the Flpe deleter (TG) using the following primer pairs: 5'GGCAGAAGCACGCTTATCG 3', primer 10: 5'GACAAGCGTTAGTAGGCACAT 3' (fragment size 343 bp); QC primer 3 as above, QC P4 as above (fragment size 585 bp).
Antibody staining and imaging
Embryos were permeablised by dehydration in methanol (25% methanol/PBS, 50% methanol/PBS, 100% methanol), bleached in 3% H 2 O 2 /methanol, rehydrated in PBS, and incubated with anti-GFP antibodies to enhance endogenous YFP signal either as whole embryos or on cross sections. Whole embryos were pre-blocked in PBS/0.1% Tween-20
(PBST) and 10% normal donkey serum (NDS) for 4 hours, incubated overnight with primary antibodies in PBST/NDS (1:500), washed extensively in PBST, and incubated with secondary antibodies (1:500) overnight. Embryos for cryosectioning were equilibrated in 30% sucrose/PBS, mounted in agar blocks (1.5% agar/5% sucrose/PBS), and frozen on dry ice.
Sections of 16 µm were cut on a Leica CM1900 cryostat and mounted on poly-lysine coated slides. Whole embryos were imaged on a Leica DM fluorescence dissecting microscope and a subset of early embryos and isolated whole tails on a Leica SP8 confocal microscope. Sections were scored on a Leica DB fluorescence microscope or with a DeltaVision Imaging system, and images acquired on a Leica SP8 confocal microscope. Antibodies used were: chicken anti-GFP 
RNA in situ hybridization
Standard methods were used to carry out mRNA in situ hybridisation in wild type CD1
embryos (Wilkinson and Nieto, 1993) . Nkx1.2 plasmid was kindly provided by Frank Schubert.
This probe includes the homeobox domain and the 3' half of the gene (nucleotides 504-1057).
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